Foresite Capital Fund IV, L.P. 13D/13G Filings for Maze Therapeutics, Inc. (MAZE)

Foresite Capital Fund IV, L.P. 13D and 13G filings for Maze Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2025-02-07
4:01 pm
Unchanged		 2025-01-31 13G Maze Therapeutics, Inc.
MAZE		 Foresite Capital Fund IV, L.P. 2,457,108
5.600%		 0
(Unchanged)		 Filing
2025-02-07
4:01 pm
Purchase		 2025-01-31 13G Maze Therapeutics, Inc.
MAZE		 Foresite Capital Fund IV, L.P. 2,457,108
5.600%		 2,457,108increase
(New Position)		 Filing